急性肾损伤生物标志物及防治的研究进展

建荣 李(大理白族自治州祥云县人民医院，中国)

摘要

急性肾损伤（Acute kidney injury,AKI）是由各种病因引起肾功能在短时间内快速减退而导致的临床综合征。AKI在世界范围内的发病率及死亡率都很高，且花费巨大。AKI已成为慢性肾脏病（Chronic kidney diseases，CKD）进展的一个公认的危险因素。论文主要针对AKI向CKD发展过程中，部分新的生物标志物及如何预防AKI后CKD的进展进行主要阐述，为临床中早期识别AKI患者并实施干预作出一定的依据。

关键词

急性肾损伤；生物标志物；干预

参考

Susantitaphong P, Cruz DN, Cerda J, et al. Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI: a meta-analysis[J]. Clin J Am Soc Nephrol, 2013(09):1482-1493.

Goldstein SL, Chawla L, Ronco C, Kellum JA. Renal recovery[J]. Crit Care, 2014(01):301.

James MT, Ghali WA, Knudtson ML, et al. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography[J]. Circulation,2011(04):409-416.

Heung M, Steffick DE, Zivin K, et al. Centers for Disease Control and Prevention CKD Surveillance Team. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data[J]. Am J Kidney Dis, 2016 (05):742-752.

Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012(02):130-138.

Kashani K, Rosner MH, Haase M, et al. Quality Improvement Goals for Acute Kidney Injury[J]. Clin J Am Soc Nephrol, 2019(06):941-953.

Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD[J]. Am J Kidney Dis, 2008(03):395-406.

Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults[J]. Ann Thorac Surg, 2009(01):124-30.

Inker LA, Schmid CH, Tighiouart H, et al. CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C[J]. N Engl J Med, 2012(01):20-29.

Herget-Rosenthal S, Marggraf G, et al. Early detection of acute renal failure by serum cystatin C[J]. Kidney Int, 2004(03):1115-22.

张毕明,肖帅,吴意.胱抑素C诊断早期急性肾损伤价值的Meta分析[J].检验医学与临床,2018(23):3485-3487+3491.

DenDenning GM, Ackermann LW, Barna TJ, et al. Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissue[J]s. Peptides, 2008(01):83-92.

Beunders R, Struck J, Wu AHB, et al. Proenkephalin (PENK) as anovel biomarker for kidney function[J]. J App Lab Med ,2017;2:400-12.

Caironi P, Latini R, Struck J, et al. ALBIOS Study Investigators. Circulating Proenkephalin, Acute Kidney Injury, and Its Improvement in Patients with Severe Sepsis or Shock[J]. Clin Chem, 2018 Sep;64(9):1361-1369.

Friedl A, Stoesz SP, Buckley P, et al. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression[J]. Histochem J, 1999(07):433-41.

Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury[J]. Nephrol Dial Transplant, 2009(11):3349-3354.

Gagliardi I, Patella G, Michael A, et al. COVID-19 and the Kidney: From Epidemiology to Clinical Practice[J]. J Clin Med, 2020(08):2506.

Albert C, Haase M, Albert A, et al. Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?[J] Ann Lab Med, 2021(01):1-15.

Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury[J]. Crit Care, 2013(01):25.

Emlet DR, Pastor-Soler N, Marciszyn A, et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells[J]. Am J Physiol Renal Physiol, 2017(02):284-296.

Hoste E, Bihorac A, Al-Khafaji A, et al. RUBY Investigators. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study[J]. Intensive Care Med, 2020(05):943-953.

Humphreys BD, Xu F, Sabbisetti V, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis[J]. J Clin Invest, 2013(09):4023-4035.

Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury[J]. Annu Rev Pharmacol Toxicol, 2008(48):463-493.

Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis[J]. Am J Kidney Dis, 2004(03):405-14.

Lin X, Yuan J, Zhao Y, et al. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis[J]. J Nephrol, 2015(01):7-16.

Stenvinkel P, Meyer CJ, Block GA, et al. Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes[J]. Nephrol Dial Transplant, 2019(13):120.

Aleksunes LM, Goedken MJ, Rockwell CE, et al. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity[J]. Pharmacol Exp Ther, 2010(01):2-12.

Nezu M, Suzuki N, Yamamoto M. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression[J]. Am J Nephrol, 2017(06):473-483.

Nezu M, Souma T, Yu L, et al. Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression[J]. Kidney Int, 2017(02):387-401.

Deregibus MC, Cantaluppi V, Calogero R,et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA[J]. Blood, 2007(07):2440-2448.

Liu C, Wang J, Hu J, et al. Extracellular vesicles for acute kidney injury in preclinical rodent models: a meta-analysis[J]. Stem Cell Res Ther, 2020(01):11.

Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells[J]. Kidney Int, 2012(04):412-27.

DOI: http://dx.doi.org/10.26549/yzlcyxzz.v3i8.6233